JPWO2019191079A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019191079A5
JPWO2019191079A5 JP2020551882A JP2020551882A JPWO2019191079A5 JP WO2019191079 A5 JPWO2019191079 A5 JP WO2019191079A5 JP 2020551882 A JP2020551882 A JP 2020551882A JP 2020551882 A JP2020551882 A JP 2020551882A JP WO2019191079 A5 JPWO2019191079 A5 JP WO2019191079A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
antigen
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020551882A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021519305A (ja
JP2021519305A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/024052 external-priority patent/WO2019191079A1/en
Publication of JP2021519305A publication Critical patent/JP2021519305A/ja
Publication of JP2021519305A5 publication Critical patent/JP2021519305A5/ja
Publication of JPWO2019191079A5 publication Critical patent/JPWO2019191079A5/ja
Pending legal-status Critical Current

Links

JP2020551882A 2018-03-26 2019-03-26 肝臓およびリンパ節の類洞内皮細胞Ｃ型レクチン（ＬＳＥＣｔｉｎ）を標的とするための方法および組成物 Pending JP2021519305A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862647911P 2018-03-26 2018-03-26
US62/647,911 2018-03-26
PCT/US2019/024052 WO2019191079A1 (en) 2018-03-26 2019-03-26 Methods and compositions for targeting liver and lymph node sinusoidal endothelial cell c-type lectin (lsectin)

Publications (3)

Publication Number Publication Date
JP2021519305A JP2021519305A (ja) 2021-08-10
JP2021519305A5 JP2021519305A5 (https=) 2022-04-01
JPWO2019191079A5 true JPWO2019191079A5 (https=) 2022-04-01

Family

ID=68060405

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020551882A Pending JP2021519305A (ja) 2018-03-26 2019-03-26 肝臓およびリンパ節の類洞内皮細胞Ｃ型レクチン（ＬＳＥＣｔｉｎ）を標的とするための方法および組成物

Country Status (4)

Country Link
US (1) US20210171642A1 (https=)
EP (1) EP3774890A4 (https=)
JP (1) JP2021519305A (https=)
WO (1) WO2019191079A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012021512A2 (en) 2010-08-10 2012-02-16 Ecole Polytechnique Federale De Lausanne Erythrocyte-binding therapeutics
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
KR102717969B1 (ko) 2014-02-21 2024-10-15 에꼴 뽈리떼끄닉 뻬데랄 드 로잔느 (으뻬에프엘) 글리코타겟팅 치료제
US11253579B2 (en) 2017-06-16 2022-02-22 The University Of Chicago Compositions and methods for inducing immune tolerance
EA202092723A1 (ru) 2018-05-09 2021-04-09 Зе Юниверсити Оф Чикаго Композиции и способы, касающиеся иммунной толерантности
CN113710229B (zh) 2019-02-25 2026-01-06 芝加哥大学 用与抗炎剂连接的ecm亲和肽治疗炎症性和自身免疫性病症的方法和组合物
KR20250005069A (ko) * 2022-02-18 2025-01-17 더 유니버서티 오브 시카고 성장호르몬 수용체 표적 폴리펩티드

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080171059A1 (en) * 2006-08-07 2008-07-17 Shanshan Wu Howland Methods and compositions for increased priming of t-cells through cross-presentation of exogenous antigens
TW200846363A (en) * 2007-03-22 2008-12-01 Urrma R & B Novel human anti-R7V antibodies and uses thereof
AU2009227935B2 (en) * 2008-03-28 2015-07-09 Mdna Life Sciences Inc. Aberrant mitochondrial DNA, associated fusion transcripts and hybridization probes therefor
WO2017044308A1 (en) * 2015-09-10 2017-03-16 Albert Einstein College Of Medicine, Inc. Synthetic antibodies to bax and uses thereof

Similar Documents

Publication Publication Date Title
JP2021519305A5 (https=)
JP7840836B2 (ja) 改善された血清アルブミン結合性免疫グロブリン可変ドメイン
JP7453206B2 (ja) 改良された血清アルブミン結合剤
JP2021191763A5 (https=)
JP2019194210A5 (https=)
JP2021503455A5 (https=)
JP7171737B2 (ja) Ｓｆｔｓｖに結合可能なナノ抗体及びその使用
JP2023071956A5 (https=)
JP2009517057A5 (https=)
TW201014602A (en) Prostaglandin E2 binding proteins and uses thereof
TW201134487A (en) Therapeutic DLL4 binding proteins
RU2765878C2 (ru) Антитела для лечения инфекции гепатитом в и связанных с ней заболеваний
JP2012504955A5 (https=)
RU2015136078A (ru) Антитело против с5 и способ предупреждения и лечения обусловленных комплементом заболеваний
JPWO2019191079A5 (https=)
JP7743406B2 (ja) 抗ｂｃｍａ ｃａｒ抗体、コンジュゲートおよび使用方法
CN119032104A (zh) 抗血清白蛋白纳米抗体及其衍生物
CN112243381B (zh) 抗bcma car抗体、缀合物和使用方法
TW201134489A (en) Basigin binding proteins
JPWO2020059847A5 (https=)
JP2020522475A5 (https=)
JPWO2021032963A5 (https=)
JP2021515597A5 (https=)
US8974786B2 (en) Humanized antibodies to CA215
CN111978393B (zh) 抗乙肝病毒新型抗体及其用途